FDA Inspection
Dana-Farber Harvard Cancer CenterDana-Farber Harvard Cancer Center – FDA Inspection, Apr 25, 2018
Record Details
This FDA Inspection record concerns Dana-Farber Harvard Cancer Center, with an inspection on April 25, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- People
- Amanda Lewin (Issuing Officer)
- Kara A. Scheibner (Company Rep)
View Company Profile
ID · 604e611c-c9b6-4b7f-b9f8-e817156e9001
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1056836
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
Other FDA inspections of Dana-Farber Harvard Cancer Center
1| Date | Classification | Office | Project area |
|---|---|---|---|
| March 25, 2011 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Dana-Farber Harvard Cancer Center
- FDA Inspection 722895 - 2011-03-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.